1. Market Research
  2. > Pharmaceutical Market Trends

Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Financial and Strategic SWOT Analysis Review

  • October 2016
  • 25 pages
  • GlobalData
Report ID: 1126249

Summary

Table of Contents

Summary

Dishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company that develops, manufactures and supplies Active Pharmaceutical Ingredients (API). The company offers a portfolio of development, scale-up and manufacturing services. The company’s product portfolio includes specialty chemicals; vitamins and chemicals; and disinfectants. Dishman’s specialty chemicals includes phase transfer catalysts, APIs, intermediates and fine chemicals; vitamins and chemicals include vitamin D2, vitamin D3 and vitamin D analogues; and disinfectants include antiseptic and disinfectant formulations among others. It also offers services such as contract research, contract manufacturing and API supply. It has its operations in India, China, Japan, the Netherlands, Switzerland, the UK and the US. Dishman is headquartered in Ahmedabad, Gujarat, India.

Dishman Pharmaceuticals and Chemicals Limited Key Recent Developments

Aug 11, 2016: Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS
Feb 09, 2015: Successful FDA inspection at the Netherlands Dishman site

This comprehensive SWOT profile of Dishman Pharmaceuticals and Chemicals Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


The profile contains critical company information including*

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.


Key benefits of buying this profile include

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Please note: this report requires certain updates. We have all the information available but require 2 working days business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Women%s Health Cluster Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • May 2017
  • by GBI Research

Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women’s health pipeline landscape. The report provides comprehensive information on the therapeutics ...

CNS Cluster Addiction Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • May 2017
  • by GBI Research

CNS Cluster Addiction Drug Development Pipeline Review, 2017 Summary This report provides an overview of the CNS Clusters pipeline landscape. The report provides comprehensive information on the therapeutics ...

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • May 2017
  • by GBI Research

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017 Summary This report provides an overview of the toxicology pipeline landscape. The report provides comprehensive ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.